HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidetaka Kawabata Selected Research

human ERBB2 protein

8/2018A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidetaka Kawabata Research Topics

Disease

23Breast Neoplasms (Breast Cancer)
01/2023 - 05/2010
12Neoplasms (Cancer)
12/2022 - 03/2010
4Neoplasm Metastasis (Metastasis)
01/2023 - 10/2019
3Triple Negative Breast Neoplasms
12/2022 - 07/2021
2Neutropenia
01/2023 - 10/2018
2Peripheral Nervous System Diseases (PNS Diseases)
04/2020 - 06/2017
2Carcinogenesis
01/2020 - 09/2017
1Alopecia (Baldness)
12/2023
1Lymphatic Metastasis
06/2023
1Neoplasm Micrometastasis
01/2022
1Pain (Aches)
04/2020
1Ovarian Neoplasms (Ovarian Cancer)
04/2020
1Carcinoma (Carcinomatosis)
12/2019
1Femoral Fractures (Femoral Fracture)
10/2019
1Osteoporosis
10/2019
1Pathologic Complete Response
08/2014
1Chronic Disease (Chronic Diseases)
03/2013
1Febrile Neutropenia
01/2013
1Infections
01/2013

Drug/Important Bio-Agent (IBA)

8Hormones (Hormone)IBA
01/2023 - 05/2018
7Estrogen ReceptorsIBA
11/2022 - 12/2019
4Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2019
4Paclitaxel (Taxol)FDA LinkGeneric
12/2022 - 06/2017
4Estrogens (Estrogen)FDA Link
11/2022 - 12/2019
4Small Interfering RNA (siRNA)IBA
11/2022 - 01/2020
4TamoxifenFDA LinkGeneric
11/2022 - 05/2018
3NivolumabIBA
01/2023 - 01/2022
3Bevacizumab (Avastin)FDA Link
12/2022 - 10/2018
3RNA (Ribonucleic Acid)IBA
11/2022 - 12/2019
3Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2017
3RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2022 - 01/2020
3taxaneIBA
12/2021 - 10/2018
3eribulinFDA Link
12/2021 - 10/2018
2Long Noncoding RNAIBA
11/2022 - 12/2019
2AnthracyclinesIBA
12/2021 - 07/2021
2Taxoids (Taxanes)IBA
12/2021 - 08/2018
2Messenger RNA (mRNA)IBA
01/2020 - 12/2019
1abemaciclibIBA
01/2023
1Fulvestrant (Faslodex)FDA Link
01/2023
1Letrozole (Femara)FDA LinkGeneric
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Alanine Transaminase (SGPT)IBA
01/2023
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2022
1B7-H1 AntigenIBA
12/2022
1Antisense RNA (Anti-Sense RNA)IBA
11/2022
1Phenobarbital (Luminal)FDA Link
11/2022
1Transcription Factors (Transcription Factor)IBA
11/2022
1LigandsIBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Organic Cation Transporter 1IBA
10/2021
1Octamer Transcription Factor-1IBA
10/2021
1Carboplatin (JM8)FDA LinkGeneric
07/2021
1Sodium Channels (Sodium Channel)IBA
04/2020
1RNA Precursors (Precursor, mRNA)IBA
01/2020
1Indicators and Reagents (Reagents)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2020
1E2F Transcription FactorsIBA
01/2020
1Thymopoietins (TP 49)IBA
12/2019
1DenosumabFDA Link
10/2019
1Trastuzumab (Herceptin)FDA Link
08/2018
1Capecitabine (Xeloda)FDA Link
08/2018
1human ERBB2 proteinIBA
08/2018
1Lapatinib (GW572016)FDA Link
08/2018
1Goserelin (Zoladex)FDA Link
05/2018
1Leuprolide (Lupron)FDA LinkGeneric
05/2018
1Tripartite Motif ProteinsIBA
09/2017
1Ligases (Synthetase)IBA
09/2017
1UbiquitinIBA
09/2017
1Cytochrome P-450 CYP2C8IBA
06/2017
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2013
1Transaminases (Aminotransferases)IBA
01/2013
1exemestane (Aromasin)FDA Link
01/2011
1Docetaxel (Taxotere)FDA Link
05/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2010
1Zoledronic Acid (Zometa)FDA Link
03/2010

Therapy/Procedure

12Therapeutics
01/2023 - 03/2013
3Drug Therapy (Chemotherapy)
12/2023 - 01/2013
3Neoadjuvant Therapy
12/2021 - 08/2014
1Radiotherapy
06/2023
1Combined Modality Therapy
01/2023
1Aftercare (After-Treatment)
12/2022